Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€0.57

€0.57

-2.630%
-0.014
-2.630%
€1.00
 
26.03.24 / Tradegate WKN: A3DZ7F / Symbol: KPRX / Name: Kiora Pharmaceuticals / Stock / Micro Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Kiora Pharmaceuticals Inc. Stock

A loss of -2.630% shows a downward development for Kiora Pharmaceuticals Inc..
Our community is currently high on Kiora Pharmaceuticals Inc. with 5 Buy predictions and 1 Sell predictions.
As a result the target price of 1 € shows a very positive potential of 76.06% compared to the current price of 0.57 € for Kiora Pharmaceuticals Inc..
For the coming years our community has positive and negative things to say abot the Kiora Pharmaceuticals Inc. stock. Criterium "Brand" gathered the most positive votes but regarding "Worthwhile Investment for the next years" there were negative voices in the community.

Pros and Cons of Kiora Pharmaceuticals Inc. in the next few years

Pros
?
W********* I********* f** t** n*** y****
?
S********** s********
?
B****
Cons
?
M***** P*******
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Comments

Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) had its "buy" rating re-affirmed by analysts at HC Wainwright.
Ratings data for KPRX provided by MarketBeat
Show more

Prediction Buy
Perf. (%) 0.00%
Target price 3.274
Change
Ends at 13.11.24

Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $3.50 price target on the stock.
Ratings data for KPRX provided by MarketBeat
Show more

Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) had its "buy" rating re-affirmed by analysts at HC Wainwright.
Ratings data for KPRX provided by MarketBeat
Show more